The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions
Open accessAbstract
BACKGROUND & AIMS: In 2017, the World Health Organization (WHO) designated clarithromycin-resistant Helicobacter pylori a high priority for antibiotic research and development. However, there are no clear data on the global distribution of resistance or its clinical effects. We performed a systematic review and meta-analysis to assess the distribution of H pylori resistance to commonly used antibiotics and to measure the association between antibiotic resistance and treatment failure. METHODS: We searched publication databases for studies that assessed rates of H pylori resistance to clarithromycin, metronidazole, levofloxacin, amoxicillin, or tetracycline. Pooled estimates of primary and secondary resistance and 95% confidence intervals (CIs) were grouped by WHO region. The association between antibiotic resistance and treatment failure was measured by extracting data on treatment efficacy in patients with resistant and susceptible isolates and pooling odds ratios with 95% CIs. RESULTS: We identified 178 studies, comprising 66,142 isolates from 65 countries. Primary and secondary resistance rates to clarithromycin, metronidazole, and levofloxacin were ≥15% in all WHO regions, except primary clarithromycin resistance in the Americas (10%; 95% CI, 4%–16%) and South-East Asia region (10%; 95% CI, 5%–16%) and primary levofloxacin resistance in the European region (11%; 95% CI, 9%–13%). There was considerable heterogeneity (I2 > 75%) among all analyses—this might have resulted from the grouping of resistance rates by country. Increasing antibiotic resistance was observed in most WHO regions. Resistance to clarithromycin was significantly associated with failure of clarithromycin-containing regimens (odds ratio, 6.97; 95% CI, 5.23–9.28; P < .001). CONCLUSIONS: Resistance of H pylori to antibiotics has reached alarming levels worldwide, which has a great effect on efficacy of treatment. Local surveillance networks are required to select appropriate eradication regimens for each region.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., Stewart, L. A., & the PRISMA-P Group (2015) · BMJ · doi:10.1136/bmj.g7647 · Cited by 13,120 · cited 1×
“5 Items for Systematic Reviews and Meta-Analyses Protocols) statement.(18) Literature published between January 2007 and June 2017 was systematically identified in PubMed using the following search terms: “(Helicobacter pylori) AND (antibiotic OR antimicrobial OR anti-microbial OR antibacterial OR anti-bacterial OR dr…”
MethodTacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
Self-citationGlobal Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
Hooi, J. K. Y., Lai, W. Y., Ng, W. K., Suen, M. M. Y., Underwood, F. E., Tanyingoh, D., Malfertheiner, P., Graham, D. Y., Wong, V. W. S., Wu, J. C. Y., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.022 · Cited by 3,375
Self-citationManagement of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
Malfertheiner, P., Megraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T., Bazzoli, F., Gasbarrini, A., Atherton, J., Graham, D. Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,946
Self-citationGlobal antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
Munn, Z., Moola, S., Riitano, D., & Lisy, K. (2014) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2014.71 · Cited by 1,479 · cited 1×
“) independently, using an adapted version of the tool proposed by the Joanna Briggs Institute for critical appraisal of prevalence studies (Supplementary Table 1).(19) A score ranging from 0 to 8 points was attributed to each study (>5 points: high quality, 4-5 points: medium quality, <4 points: low quality).”
MethodLee, Y.-C., Chiang, T.-H., Chou, C.-K., Tu, Y.-K., Liao, W.-C., Wu, M.-S., & Graham, D. Y. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.028 · Cited by 1,013
Self-citationH pylori antibiotic resistance: prevalence, importance, and advances in testing
Mégraud, F. (2004) · Gut · doi:10.1136/gut.2003.022111 · Cited by 955
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults
Fallone, C. A., Chiba, N., van Zanten, S. V., Fischbach, L., Gisbert, J. P., Hunt, R. H., Jones, N. L., Render, C., Leontiadis, G. I., Moayyedi, P., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.04.006 · Cited by 927
Megraud, F., Coenen, S., Versporten, A., Kist, M., Lopez-Brea, M., Hirschl, A. M., Andersen, L. P., Goossens, H., Glupczynski, Y., & on behalf of the Study Group participants (2013) · Gut · doi:10.1136/gutjnl-2012-302254 · Cited by 839
Review article: the global emergence of Helicobacter pylori antibiotic resistance
Thung, I., Aramin, H., Vavinskaya, V., Gupta, S., Park, J. Y., Crowe, S. E., & Valasek, M. A. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13497 · Cited by 743
The prevalence of Helicobacter pylori infection in different countries.
Pounder, R. E., & Ng, D. K. (1995) · PubMed · Cited by 719
(2012) · PubMed · Cited by 570
Worldwide H. pylori antibiotic resistance: a systematic review.
Francesco, V. D., Giorgio, F., Hassan, C., Manes, G., Vannella, L., Panella, C., Ierardi, E., & Zullo, A. (2010) · PubMed · Cited by 560
Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition
Asaka, M., Kato, M., Takahashi, S., Fukuda, Y., Sugiyama, T., Ota, H., Uemura, N., Murakami, K., Satoh, K., & Sugano, K. (2010) · Helicobacter · doi:10.1111/j.1523-5378.2009.00738.x · Cited by 395
A Report Card to Grade Helicobacter pylori Therapy
Graham, D. Y., Lu, H., & Yamaoka, Y. (2007) · Helicobacter · doi:10.1111/j.1523-5378.2007.00518.x · Cited by 393
Self-citationKuo, Y.-T., Liou, J.-M., El-Omar, E. M., Wu, J.-Y., Leow, A. H. R., Goh, K. L., Das, R., Lu, H., Lin, J.-T., Tu, Y.-K., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30219-4 · Cited by 319
Liou, J.-M., Chen, C.-C., Chen, M.-J., Chen, C.-C., Chang, C.-Y., Fang, Y.-J., Lee, J., Hsu, S.-J., Luo, J.-C., Chang, W.-H., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61579-7 · Cited by 269
Wu, D., Hsu, P., Wu, J., Opekun, A. R., Kuo, C., Wu, I. –., Wang, S. S. W., Chen, A., Hung, W., & Graham, D. Y. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.09.030 · Cited by 245
Self-citationYang, J.-C., Lin, C.-J., Wang, H.-L., Chen, J.-D., Kao, J. Y., Shun, C.-T., Lu, C.-W., Lin, B.-R., Shieh, M.-J., Chang, M.-C., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.036 · Cited by 202
Liou, J.-M., Fang, Y.-J., Chen, C.-C., Bair, M.-J., Chang, C.-Y., Lee, Y.-C., Chen, M.-J., Chen, C.-C., Tseng, C.-H., Hsu, Y.-C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31409-x · Cited by 199
Self-medication in children and adolescents
Pereira, F. S. V. T., Bucaretchi, F., Stephan, C., & Cordeiro, R. (2007) · Jornal de Pediatria · doi:10.2223/jped.1703 · Cited by 175
Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans
Shiota, S., Reddy, R., Alsarraj, A., El‐Serag, H. B., & Graham, D. Y. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.02.005 · Cited by 163
Self-citationRokkas, T., Rokka, A., & Portincasa, P. (2017) · Annals of Gastroenterology · doi:10.20524/aog.2017.0144 · Cited by 144
Hwang, T. J., Kim, N., Kim, H. B., Lee, B. H., Nam, R. H., Park, J. H., Lee, M. K., Park, Y. S., Lee, D. H., Jung, H. C., et al. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181d04592 · Cited by 140
Zhang, Y.-X., Zhou, L.-Y., Song, Z.-Q., Zhang, J.-Z., He, L.-H., & Ding, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i9.2786 · Cited by 137
Antibiotic treatment for Helicobacter pylori : Is the end coming?
Kim, S. Y., Choi, D. J., & Chung, J.-W. (2015) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v6.i4.183 · Cited by 118
Liou, J., Lin, J.-T., Chang, C.-Y., Chen, M., Cheng, T., Lee, Y., Chen, C.-J., Sheng, W., Wang, H., & Wu, M. (2010) · Gut · doi:10.1136/gut.2009.198309 · Cited by 118
Kuo, C.-H., Hu, H., Kuo, F., Hsu, P., Chen, A., Yu, F., Tsai, P.-Y., Wu, I., Wang, S.-W., Li, C.-J., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp034 · Cited by 99
Deyi, V. Y. M., Bontems, P., Vanderpas, J. B., Koster, E. D., Ntounda, R., den Borre, C. V., Cadranel, S., & Burette, A. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02642-10 · Cited by 84
Ducournau, A., Bénéjat, L., Sifré, E., Bessède, E., Lehours, P., & Mégraud, F. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.06.003 · Cited by 84
Federico, A., Nardone, G., Gravina, A. G., Iovene, M. R., Miranda, A., Compare, D., Pilloni, A. P., Rocco, A., Ricciardiello, L., Marmo, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.043 · Cited by 83
Phan, T. N., Santona, A., Tran, V. H., Tran, T. N. H., Lê, V. A., Cappuccinelli, P., Rubino, S., & Paglietti, B. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.10.019 · Cited by 80
The Incidence of Primary Antibiotic Resistance of Helicobacter pylori in Vietnam
Bình, T. T., Shiota, S., Nguyen, L. T., Dung, H. D. Q., Hoang, H. H., Ta, L., Trinh, D. T., Fujioka, T., & Yamaoka, Y. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182676e2b · Cited by 73
Siavoshi, F., Saniee, P., Latifi‐Navid, S., Massarrat, S., & Haj-Sheykholeslami, A. (2010) · PubMed · Cited by 73
Miftahussurur, M., Syam, A. F., Nusi, I. A., Makmun, D., Waskito, L. A., Zain, L. H., Akil, F., Uwan, W. B., Simanjuntak, D., Wibawa, I. D. N., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166199 · Cited by 71
Chung, J., Jung, Y. K., Kim, Y. J., Kwon, K. A., Kim, J. H., Lee, J. J., Lee, S. M., Hahm, K. B., Lee, S., Jeong, J. Y., et al. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07249.x · Cited by 66
Resistance ofHelicobacter pylorito antibiotics from 2000 to 2009 in Shanghai
Sun, Q.-J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i40.5118 · Cited by 66
Treating Helicobacter pylori effectively while minimizing misuse of antibiotics
Shiotani, A., Lü, H., Dore, M. P., & Graham, D. Y. (2017) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.84a.14110 · Cited by 65
Self-citationSequential versus standard triple first-line therapy forHelicobacter pylorieradication
Nyssen, O. P., McNicholl, A. G., Mégraud, F., Savarino, V., Oderda, G., Fallone, C. A., Fischbach, L. A., Bazzoli, F., & Gisbert, J. P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009034.pub2 · Cited by 62
Sequential Therapy Versus Tailored Triple Therapies for Helicobacter pylori Infection in Children
Bontems, P., Kalach, N., Oderda, G., Salame, A., Muyshont, L., Miendje, D. Y., Raymond, J., Cadranel, S., & Scaillon, M. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318229c769 · Cited by 61
Abadi, A. T. B., Taghvaei, T., Mobarez, A. M., Carpenter, B. M., & Merrell, D. S. (2011) · The Journal of Microbiology · doi:10.1007/s12275-011-1170-6 · Cited by 58
Ji, Z., Han, F., Meng, F., Tu, M., Yang, N., & Zhang, J. (2016) · Medicine · doi:10.1097/md.0000000000002831 · Cited by 58
Molecular Detection of Helicobacter pylori and its Antimicrobial Resistance in Brazzaville, Congo
Ngoyi, E. N. O., Ibara, B. I. A., Moyen, R., Apendi, P. C. M. A., Ibara, J. R., Obengui, O., Ibara, R. B. O., Nguimbi, E., Niama, R. F., Ouamba, J. M., et al. (2015) · Helicobacter · doi:10.1111/hel.12204 · Cited by 52
Antibiotic-Resistant Helicobacter pylori Strains in Portuguese Children
Lopes, A. I., Oleastro, M., Palha, A. M., Fernandes, A., & Monteiro, L. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000160941.65324.6b · Cited by 50
Aftab, H., Miftahussurur, M., Subsomwong, P., Ahmed, F., Khan, A. A., & Yamaoka, Y. (2016) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.7713 · Cited by 50
Georgopoulos, S. D., Xirouchakis, E., Martinez‐Gonzalez, B., Zampeli, E., Grivas, E., Spiliadi, C., Sotiropoulou, M. G., Petraki, K., Zografos, K., Laoudi, F., et al. (2016) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2016.04.011 · Cited by 48
Farshad, S. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i45.5746 · Cited by 47
Molecular detection ofHelicobacter pyloriantibiotic resistance in stoolvsbiopsy samples
Brennan, D. E., Omorogbe, J. A., Hussey, M., Tighe, D., Holleran, G. E., O'Morain, C. A., Smith, S. M., & McNamara, D. A. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i41.9214 · Cited by 46
Five-year sequential changes in secondary antibiotic resistance ofHelicobacter pyloriin Taiwan
Wu, I. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10669 · Cited by 40
Bouihat, N., Burucoa, C., Benkirane, A., Seddik, H., Sentissi, S., Bouzidi, A. A., Elouennas, M., & Benouda, A. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0264 · Cited by 39
Cheng, A., Sheng, W., Liou, J., Wang, H.-P., Wu, M., Lin, J., & Chang, S. (2012) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2012.08.021 · Cited by 38
Attempts to enhance the eradication rate ofHelicobacter pyloriinfection
Bang, C. S., & Baik, G. H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5252 · Cited by 37
Fu, W., Song, Z., Zhou, L., Xue, Y., Ding, Y., Suo, B., Tian, X., & Wang, L. J. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4564-4 · Cited by 34
Karczewska, E., Wojtas-Bonior, I., Sito, E., et al. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70592-8 · Cited by 33
Marín, A. C., Nyssen, O. P., McNicholl, A. G., et al. (2017) · Drugs · doi:10.1007/s40265-017-0730-4 · Cited by 31
Drug resistance pattern and clonality in H. pylori strains
Nath, G., Singh, V., Mishra, S., Maurya, P., Rao, G., Jain, A. K., Dixit, V. K., & Gulati, A. K. (2009) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.60 · Cited by 30
Morse, A. L., Goodman, K. J., Munday, R., Chang, H.-J., Morse, J., Keelan, M., Geary, J., van Zanten, S. V., & CAN Help Working Group (2013) · Canadian Journal of Gastroenterology · doi:10.1155/2013/143047 · Cited by 29
Chen, K.-Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i36.10435 · Cited by 29
Karczewska, E., Klesiewicz, K., Skiba‐Kurek, I., et al. (2012) · Gastroenterology Research and Practice · doi:10.1155/2012/418010 · Cited by 23
Risk factors associated withHelicobacter pyloriinfection treatment failure in a high prevalence area
Yakoob, J., Jafri, W., Abbas, Z., Abid, S., Naz, S., Khan, R., & KHALID, A. (2010) · Epidemiology and Infection · doi:10.1017/s0950268810001226 · Cited by 23
Kupčinskas, L., Rasmussen, L., Jonaitis, L. V., Kiudelis, G., Jørgensen, M. H., Urbonavičienė, N., Tamošiūnas, V., Kupčinskas, J., Miciulevičienė, J., Kaduševičius, E., et al. (2012) · Apmis · doi:10.1111/apm.12012 · Cited by 21
Han, R., Lü, H., Jiang, M.-W., Tan, K.-W., Peng, Z., Hu, J., Fang, D.-C., Lan, C., & Wu, X. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/8547686 · Cited by 21
Prapitpaiboon, H., Mahachai, V., & Vilaichone, R. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.10.4353 · Cited by 18
Wu, D., Kuo, C., Tsay, F., Hsu, W., Chen, A. C.-Y., & Hsu, P. (2016) · Medicine · doi:10.1097/md.0000000000002698 · Cited by 18
Antibiotics resistance rate ofHelicobacter pyloriin Bhutan
Vilaichone, R., Yamaoka, Y., Shiota, S., Ratanachu-ek, T., Tshering, L., Uchida, T., Fujioka, T., & Mahachai, V. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i33.5508 · Cited by 17
Ramzy, I. I., El-Garem, H., Hamza, I., et al. (2016) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946201658088 · Cited by 15
Moghaddam, A. B., Alebouyeh, M., Farzi, N., et al. (2016) · PubMed · Cited by 6
Cited by
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Malfertheiner, P., Camargo, M. C., El-Omar, E., Liou, J.-M., Peek, R., Schulz, C., Smith, S. I., & Suerbaum, S. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00431-8 · Cited by 1,191
Helicobacter pylori infection and antibiotic resistance — from biology to clinical implications
Tshibangu-Kabamba, E., & Yamaoka, Y. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00449-x · Cited by 517
Liou, J.-M., Malfertheiner, P., Lee, Y.-C., Sheu, B.-S., Sugano, K., Cheng, H.-C., Yeoh, K.-G., Hsu, P.-I., Goh, K.-L., Mahachai, V., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322368 · Cited by 493
Self-citationCrowe, S. E. (2019) · New England Journal of Medicine · doi:10.1056/nejmcp1710945 · Cited by 467
Metadata
- Authors
- Savoldi, A., Carrara, E., Graham, D. Y., Conti, M., & Tacconelli, E.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2018-11
- Volume
- 155
- Issue
- 5
- Pages
- 1372-1382.e17
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2881320234
- Cited by
- 1,270
- References
- 71
- FWCI
- 24.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.